Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Reduction of smoking urges with intranasal insulin: a randomized, crossover, placebo-controlled clinical trial

Molecular Psychiatry volume 22, pages 1413–1421 (2017)Cite this article

Subjects

Abstract

Many cigarette smokers express a desire to quit smoking, but ~85% of cessation attempts fail. In our attempt to delineate genetic modulators of smoking persistence, we have earlier shown that a locus within an ~250 kb haplotype block spanning the 5' untranslated region region of insulin-degrading enzyme is associated with serum cotinine levels; the study’s measure of smoking quantity. Based on our findings, and coupled with recent preclinical studies showing the importance of multiple neuropeptides in reinstatement of drug use, we formulated intranasal insulin to evaluate its efficacy during acute abstinence from smoking. Our original study was a crossover trial including 19 otherwise healthy smokers who abstained from smoking for 36 h. The morning following their second night of abstinence, in random order, study participants received intranasal insulin (60 IU) or placebo (8.7% sodium chloride). The goal of our second study was to replicate the craving findings from the original trial and expand this research by including additional stress-related measures. Thirty-seven study participants abstained from smoking overnight. The next day, they were administered either intranasal insulin (60 IU) or placebo, following which they participated in the Trier Social Stress Test Task. This was a parallel design study focusing on the standard stress subjective, hormonal and cardiovascular measures. We also evaluated any changes in circulating glucose, insulin and c-peptide (a marker of endogenous insulin). In the original study, intranasal insulin significantly reduced morning nicotine craving (b=3.65, P⩽0.05). Similarly, in the second study, intranasal insulin reduced nicotine cravings over time (b=0.065, P⩽0.05) and the effect lasted through the psychosocial stress period. Intranasal insulin also increased circulating cortisol levels (F=12.78, P⩽0.001). No changes in insulin or c-peptide were detected. A significant treatment × time interaction (P⩽0.05) was detected for glucose, but subjects remained well within the euglycemic range. Previous studies have shown that heightened nicotine cravings and blunted response to stress are independent and significant predictors of relapse to smoking. In our study, intranasal insulin normalized the subjective and hormonal response to stress. As such, intranasal insulin should further be studied in a larger clinical trial of smoking cessation. In support of this, we provide evidence that the treatment is safe and effective and, based on absence of peripheral insulin changes, conclude that the pharmacodynamic effect is centrally driven.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

Similar content being viewed by others

References

  1. Tiffany ST, Wray JM . The clinical significance of drug craving. Ann NY Acad Sci 2012; 1248: 1–17.

    Article  CAS  Google Scholar 

  2. Ferguson SG, Shiffman S . The relevance and treatment of cue-induced cravings in tobacco dependence. J Subst Abuse Treat 2009; 36: 235–243.

    Article  Google Scholar 

  3. Brandon TH, Drobes DJ, Unrod M, Heckman BW, Oliver JA, Roetzheim RC et al. Varenicline effects on craving, cue reactivity, and smoking reward. Psychopharmacology (Berl) 2011; 218: 391–403.

    Article  CAS  Google Scholar 

  4. Kwako LE, Spagnolo PA, Schwandt ML, Thorsell A, George DT, Momenan R et al. The corticotropin releasing hormone-1 (CRH1) receptor antagonist pexacerfont in alcohol dependence: a randomized controlled experimental medicine study. Neuropsychopharmacology 2015; 40: 1053–1063.

    Article  CAS  Google Scholar 

  5. Al'Absi M, Hatsukami D, Davis GL . Attenuated adrenocorticotropic responses to psychological stress are associated with early smoking relapse. Psychopharmacology 2005; 181: 107–117.

    Article  CAS  Google Scholar 

  6. Sinha R, Fox HC, Hong KI, Hansen J, Tuit K, Kreek MJ . Effects of adrenal sensitivity, stress- and cue-induced craving, and anxiety on subsequent alcohol relapse and treatment outcomes. Arch Gen Psychiatry 2011; 68: 942–952.

    Article  CAS  Google Scholar 

  7. Hamidovic A, Goodloe RJ, Bergen AW, Benowitz NL, Styn MA, Kasberger JL et al. Gene-centric analysis of serum cotinine levels in African and European American populations. Neuropsychopharmacology 2012; 37: 968–974.

    Article  CAS  Google Scholar 

  8. Schank JR, Ryabinin AE, Giardino WJ, Ciccocioppo R, Heilig M . Stress-related neuropeptides and addictive behaviors: beyond the usual suspects. Neuron 2012; 76: 192–208.

    Article  CAS  Google Scholar 

  9. Mineur YS, Abizaid A, Rao Y, Salas R, DiLeone RJ, Gündisch D et al. Nicotine decreases food intake through activation of POMC neurons. Science 2011; 332: 1330–1332.

    Article  CAS  Google Scholar 

  10. Seeley RJ, Woods SC . Monitoring of stored and available fuel by the CNS: implications for obesity. Nat Rev Neurosci 2003; 4: 901–909.

    Article  CAS  Google Scholar 

  11. Exley R, Cragg SJ . Presynaptic nicotinic receptors: a dynamic and diverse cholinergic filter of striatal dopamine neurotransmission. Br J Pharmacol 2008; 153 (Suppl 1): S283–S297.

    CAS  PubMed  Google Scholar 

  12. Cachope R, Mateo Y, Mathur BN, Irving J, Wang HL, Morales M et al. Selective activation of cholinergic interneurons enhances accumbal phasic dopamine release: setting the tone for reward processing. Cell Rep 2012; 2: 33–41.

    Article  CAS  Google Scholar 

  13. Stouffer MA, Woods CA, Patel JC, Lee CR, Witkovsky P, Bao L et al. Insulin enhances striatal dopamine release by activating cholinergic interneurons and thereby signals reward. Nat Commun 2015; 6: 8543.

    Article  CAS  Google Scholar 

  14. Labouèbe G, Liu S, Dias C, Zou H, Wong JC, Karunakaran S et al. Insulin induces long-term depression of ventral tegmental area dopamine neurons via endocannabinoids. Nat Neurosci 2013; 16: 300–308.

    Article  Google Scholar 

  15. Born J, Lange T, Kern W, McGregor GP, Bickel U, Fehm HL . Sniffing neuropeptides: a transnasal approach to the human brain. Nat Neurosci 2002; 5: 514–516.

    Article  CAS  Google Scholar 

  16. Middleton ET, Morice AH . Breath carbon monoxide as an indication of smoking habit. Chest 2000; 117: 758–763.

    Article  CAS  Google Scholar 

  17. Stunkard AJ, Messick S . The three-factor eating questionnaire to measure dietary restraint, disinhibition and hunger. J Psychosom Res 1985; 29: 71–83.

    Article  CAS  Google Scholar 

  18. Selzer ML . The Michigan alcoholism screening test: the quest for a new diagnostic instrument. Am J Psychiatry 1971; 127: 1653–1658.

    Article  CAS  Google Scholar 

  19. McKee SA, Weinberger AH, Shi J, Tetrault J, Coppola S . Developing and validating a human laboratory model to screen medications for smoking cessation. Nicotine Tob Res 2012; 14: 1362–1371.

    Article  CAS  Google Scholar 

  20. Cox LS, Tiffany ST, Christen AG . Evaluation of the brief questionnaire of smoking urges (QSU-brief) in laboratory and clinical settings. Nicotine Tob Res 2001; 3: 7–16.

    Article  CAS  Google Scholar 

  21. Watson D, Clark LA, Tellegen A . Development and validation of brief measures of positive and negative affect: the PANAS scales. J Pers Soc Psychol 1988; 54: 1063–1070.

    Article  CAS  Google Scholar 

  22. Shiffman S, Hickcox M, Paty JA, Gnys M, Richards T, Kassel JD . Individual differences in the context of smoking lapse episodes. Addict Behav 1997; 22: 797–811.

    Article  CAS  Google Scholar 

  23. NicotrolNS(R) [package insert]. Pfizer, New York, NY; January 2010; Available at: https://www.pfizer.com/files/products/uspi_nicotrol.pdf.

  24. Claxton A, Baker LD, Hanson A, Trittschuh EH, Cholerton B, Morgan A et al. Long acting intranasal insulin detemir improves cognition for adults with mild cognitive impairment or early-stage Alzheimer's disease dementia. J Alzheimers Dis 2015; 45: 1269–1270.

    Article  Google Scholar 

  25. Craft S, Baker LD, Montine TJ, Minoshima S, Watson GS, Claxton A et al. Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial. Arch Neurol 2012; 69: 29–38.

    Article  Google Scholar 

  26. Hamidovic A . Position on zinc delivery to olfactory nerves in intranasal insulin phase I-III clinical trials. Contemp Clin Trials 2015; 45 (Pt B): 277–280.

    Article  CAS  Google Scholar 

  27. Lehrer S . Adverse side effects of intranasal detemir insulin in the SNIFF Trial. J Alzheimers Dis 2015; Available at: http://www.j-alz.com/content/adverse-side-effects-intranasal-detemir-insulin-sniff-trial.

  28. Woods CA, Guttman ZR, Huang D, Kolaric RA, Rabinowitsch AI, Jones KT et al. Insulin receptor activation in the nucleus accumbens reflects nutritive value of a recently ingested meal. Physiol Behav 2016; 159: 52–63.

    Article  CAS  Google Scholar 

  29. Figlewicz DP, Bennett JL, Aliakbari S, Zavosh A, Sipols AJ . Insulin acts at different CNS sites to decrease acute sucrose intake and sucrose self-administration in rats. Am J Physiol Regul Integr Comp Physiol 2008; 295: R388–R394.

    Article  CAS  Google Scholar 

  30. Lee J, Finkelstein J, Choi JY, Witten IB . Linking cholinergic interneurons, synaptic plasticity, and behavior during the extinction of a cocaine-context association. Neuron 2016; 90: 1071–1085.

    Article  CAS  Google Scholar 

  31. Chan O, Inouye K, Akirav E, Park E, Riddell MC, Vranic M et al. Insulin alone increases hypothalamo-pituitary-adrenal activity, and diabetes lowers peak stress responses. Endocrinology 2005; 146: 1382–1390.

    Article  CAS  Google Scholar 

  32. Bohringer A, Schwabe L, Richter S, Schachinger H . Intranasal insulin attenuates the hypothalamic-pituitary-adrenal axis response to psychosocial stress. Psychoneuroendocrinology 2008; 33: 1394–1400.

    Article  CAS  Google Scholar 

  33. Obici S, Zhang BB, Karkanias G, Rossetti L . Hypothalamic insulin signaling is required for inhibition of glucose production. Nat Med 2002; 8: 1376–1382.

    Article  CAS  Google Scholar 

  34. Kimura K, Tanida M, Nagata N, Inaba Y, Watanabe H, Nagashimada M et al. Central insulin action activates kupffer cells by suppressing hepatic vagal activation via the nicotinic alpha 7 acetylcholine receptor. Cell Rep 2016; 14: 2362–2374.

    Article  CAS  Google Scholar 

  35. Ruigrok MJR, de Lange ECM . Emerging Insights for translational pharmacokinetic and pharmacokinetic-pharmacodynamic studies: towards prediction of nose-to-brain transport in humans. AAPS J 2015; 17: 493–505.

    Article  CAS  Google Scholar 

  36. Illum L . Is nose-to-brain transport of drugs in man a reality? J Pharm Pharmacol 2004; 56: 3–17.

    Article  CAS  Google Scholar 

  37. Dhuria SV, Hanson LR, Frey WH . Intranasal delivery to the central nervous system: mechanisms and experimental considerations. J Pharm Scie 2010; 99: 1654–1673.

    Article  CAS  Google Scholar 

  38. Balin BJ, Broadwell RD, Salcman M, El-Kalliny M . Avenues for entry of peripherally administered protein to the central nervous system in mouse, rat, and squirrel monkey. J Comp Neurol 1986; 251: 260–280.

    Article  CAS  Google Scholar 

  39. Salameh TS, Bullock KM, Hujoel IA, Wolden-Hanson T, Banks WA, Niehoff ML et al. Central nervous system delivery of intranasal insulin: mechanisms of uptake and effects on cognition. J Alzheimers Dis 2015; 47: 715–728.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This work was supported by NIH/NIDA (1R03DA036054 and 1R03DA03827), American Cancer Society Institutional Research Grant IRG-92-024, 8UL1TR000041 and P-50 AA022534.

Author information

Authors and Affiliations

  1. Department of Pharmacy Practice, University of Illinois at Chicago College of Pharmacy, Chicago, IL, USA

    A Hamidovic

  2. University of New Mexico, Albuquerque, NM, USA

    M Khafaja, V Brandon, J Anderson, G Ray, A M Allan & M R Burge

Authors
  1. A Hamidovic
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M Khafaja
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. V Brandon
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. J Anderson
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. G Ray
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. A M Allan
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. M R Burge
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to A Hamidovic.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Additional information

Supplementary Information accompanies the paper on the Molecular Psychiatry website

Supplementary information

PowerPoint slides

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hamidovic, A., Khafaja, M., Brandon, V. et al. Reduction of smoking urges with intranasal insulin: a randomized, crossover, placebo-controlled clinical trial. Mol Psychiatry 22, 1413–1421 (2017). https://doi.org/10.1038/mp.2016.234

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/mp.2016.234

This article is cited by

Search

Advanced search

Quick links